Chromocell Therapeutics Overview
Chromocell Therapeutics Discounted Cash Flow
DCF Analysis for CHRO.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.30
Current Fair Value
$-0.30
↓ 122.2% Downside
Overvalued by 122.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison